Immediate-release oral tablets for selective phosphodiesterase inhibition in bronchospasm relief. Obtained by community pharmacies and healthcare networks for outpatient prescriptions. Manufactured by contract developers for wholesale channels targeting pulmonologists and asthma management programs.